Abstract
Considering the biological effects of nitric oxide (NO) in the heart and thus its pathophysiological significance in cardiac diseases four major compartments have to be discerned: the blood within the coronary circulation, endocardial and coronary endothelial cells, coronary smooth muscle cells, and cardiomyocytes (see Fig. 1). In contrast, cardiac fibroblasts do not appear to synthesize NO [1]. Under baseline conditions nitric oxide is continuously synthesized from L-arginine within the vascular endothelium. It is released to the luminal side where it inhibits the adhesion of platelets, monocytes and neutrophils, all of which play a key role in the development of an atherosclerotic lesion [2–6]. In addition, NO is also released to the abluminal side where it exerts short-term and long-term effects on coronary vasculature and thus represents an important modulator of coronary vascular tone [7, 8]. Furthermore, NO is capable of modulating cardiac contractility, not only by its effects on coronary flow, but also via direct effects on cardiomyocytes [9, 10]. In addition, preliminary data suggest that NO modulates the release of norepinephrine from cardiac neurons, thus affecting cardiac contractility [2, 11].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Shindo T, Ikeda U, Ohkawa F, Takahashi M, Funayama H, Nishinaga M, Kawahara Y, Yokoyama M, Kasahara T, Shimada K (1994) Nitric oxide synthesis in rat cardiac myocytes and fibroblasts. Life Sci 55: 1101–1108
Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002–2012
Dzau VJ, Gibbons GH, Morishita R, Pratt RE (1994) New perspectives in hypertension research: Potentials of vascular biology. Hypertension 23: 1132–1139
Ross R (1986) The pathogenesis of atherosclerosis — an update. N Engl J Med 324 (8): 488–500
Radomski MW, Moncada S (1993) Regulation of vascular homeostasis by nitric oxide. Thromb Haemost 70: 36–41
Snyder SH, Bredt DS (1992) Biological roles of nitric oxide. Sci Am 266 (5): 68–77
Furchgott RF, Vanhoutte PM (1989) Endothelium-derived relaxing and contracting factors. FASEB J 3: 2007–2018
Kelm M, Schrader J (1990) Control of coronary vascular tone by nitric oxide. Circ Res 66: 1561–1575
de Beider AJ, Radomski MW, Martin JF, Moncada S (1995) Nitric oxide and the pathogenesis of heart muscle disease. Eur J Clin Invest 25: 1–8
Ungureanu-Longrois D, Balligand JL, Kelly RA, Smith TW (1995) Myocardial contractile dysfunction in the systemic inflammatory response syndrome: Role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol 27: 155–167
Knowles RG, Moncada S (1994) Nitric oxide synthases in mammals. Biochem J 298: 249–258
Schulz R, Nava E, Moncada S (1992) Induction and potential biological relevance of a Ca2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol 105: 575–580
Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuk GD (1995) The role of nitric oxide in cardiac depression induced by interleukin-1 β and tumour necrosis factor-α. Br J Pharmacol 114: 27–34
Lancaster Jr. JR (1994) Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA 91: 8137–8141
Kelm M, Feelisch M, Krebber T, Deussen A, Motz W, Strauer BE (1995) The role of nitric oxide (NO) in the regulation of coronary vascular tone in hearts from hypertensive rats: maintenance of NO forming capacity and increased basal production of NO. Hypertension 25: 186–193
Kelm M, Feelisch M, Spahr R, Piper H, Noack E, Schrader J (1988) Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells. Biochem Biophys Res Commun 154: 236–244
Kelm M, Feelisch M, Deussen A, Schrader J, Strauer BE (1991) The role of nitric oxide in the control of coronary vascular tone in relation to partial oxygen pressure, perfusion pressure and flow. J Cardiovasc Pharmacol 17 (Suppl III): 95–99
Kelm M, Feelisch M, Grube R, Motz W, Strauer BE (1992) Metabolism of endothelium-derived nitric oxide in human blood. In: Moncada S (ed) The biology of nitric oxide. Portland, Colchester, pp 319–322
Kelm M, Yoshida K (1996) Metabolic fate of nitric oxide in vitro and in vivo. In: Feelisch M, Stamler J (eds) Methods in nitric oxide research. Wiley, Chichester pp 46–58
Brady AJB, Poole-Wison PA, Harding SE, Warren JB (1992) Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 1963–1966
Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T (1993) Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA 90: 347–351
Snyder SH (1994) Nitric oxide: More jobs for that molecule. Nature 372: 504–505
Schrader J (1990) Adenosine a homeostatic metabolite in cardiac energy metabolism. Circulation 81: 389–391
Deussen A, Schrader J (1991) Cardiac adenosine production is linked to myocardial pO2. J Mol Cell Cardiol 23: 495–504
Kammermeier H (1993) Meaning of energetic parameters. Basic Res Cardiol 88: 380–384
Radi R, Rodriguez M, Castro L, Telleri R (1994) Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 308: 89–95
Brown GC (1995) Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett 369: 136–139
de Belder AJ, Radomski MW, Why HJ, Richardson PJ, Martin JF (1995) Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. Br Heart J 74: 426–430
Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE (1989) The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321: 280–287
Finkel MS, Oddis CV, Jacobs TD, Watkins SC, Hattler BG, Simmons RL (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387–389
van Dissel JT, Groeneveld PHP, Maes B, van Furth R, Frolich M, Feuth HDM (1994) Nitric oxide: a predictor of morbidity in postoperative patients? Lancet 343: 1579–1580
Yang X, Chowdhury N, Brett J, Marboe C, Sciacca RR, Michler RE, Cai B, Cannon PJ (1994) Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest 94: 714–721
de Belder AJ, Radomski MW, Why HJF, Richardson PJ, Bucknall CA, Salas E, Martin JF, Moncada S (1993) Nitric oxide synthase activities in human myocardium. Lancet 341: 84–85
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kelm, M., Yilmaz, B. (1997). The Role of NO Synthases in Immunological Diseases: Importance for Left Ventricular Function. In: Schultheiss, HP., Schwimmbeck, P. (eds) The Role of Immune Mechanisms in Cardiovascular Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60463-8_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-60463-8_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61358-9
Online ISBN: 978-3-642-60463-8
eBook Packages: Springer Book Archive